BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Retina
,
Human chorionic gonadotropin
,
Doxorubicin
,
rs4950928
,
LEP
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ClC 3
Summary
General Info
Curated Studies
Most Correlated Studies
Hepatocellular carcinomas from patients of Chinese origin
Retinas from 12wk old mice 2d after optic nerve crush or sham procedures
Blood from pediatric patients with early-to-moderate onset atopic dermatitis
Explore Curated Studies Results
Literature
Most Relevant Literature
ClC-3: A Novel Promising Therapeutic Target for Atherosclerosis.
ClC-3 induction protects against cerebral ischemia/reperfusion injury through promoting Beclin1/Vps3…
Chloride channel-3 promotes tumor metastasis by regulating membrane ruffling and is associated with …
Chloride/proton antiporters ClC3 and ClC5 support bone formation in mice.
CLCN3 in mediating the proliferation of human ovarian cancer cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression
CLC Parent-Child Emotional Preparation Program
Simulation Training of Closed-Loop Communication (CLC)
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Wom…
Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ